Analysen von Matthew Weston

25.05.18 Roche Underperform Credit Suisse Group
20.04.18 Novartis Underperform Credit Suisse Group
18.04.18 Roche Neutral Credit Suisse Group
24.01.18 Novartis Neutral Credit Suisse Group
25.01.18 Novartis Underperform Credit Suisse Group
31.10.16 Novo Nordisk Neutral Credit Suisse Group
08.08.16 Novo Nordisk Neutral Credit Suisse Group
20.05.15 Merck Outperform Credit Suisse Group
19.10.11 Merck neutral Credit Suisse Group
28.07.11 Merck neutral Credit Suisse Group